Sanofi

News

Sanofi/GSK restart COVID-19 vaccine trials after tweaking fo...

Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag late last year.

News

Sanofi steps in to boost supplies of Pfizer/BioNTech's COVID...

Sanofi has said it is to begin manufacturing the COVID-19 shot from Pfizer and BioNTech in a week when supplies are in the spotlight.

News

Sanofi buys UK's Kymab and inflammatory disease hopeful for ...

Sanofi is to acquire UK biotech Kymab in a deal worth up to $1.45 billion as the big French pharma seeks to add to its pipeline of drugs that treat inflammatory diseases and cancer.

News

Blurred figures of people with medical uniforms in hospital corridor

IL-6 drugs do work in COVID-19, says UK, as it plans NHS use

New data means that IL-6 drugs from Roche and Sanofi that had been all-but written off as coronavirus therapies will now be offered routinely to COVID-19 patients in intensive care in the

Views & Analysis

The top 5 pharma M&A deals of 2020

2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers –

News

EUSA Pharma hopes IL-6 drug will succeed in COVID-19 where r...

UK-based EUSA Pharma has begun a late-stage trial of its antibody siltuximab in COVID-19, hoping that the IL-6 inhibitor will succeed where class rivals from Roche and Sanofi/Regeneron have

Sanofi/GSK restart COVID-19 vaccine trials after tweaking fo...

Sanofi steps in to boost supplies of Pfizer/BioNTech's COVID...

Sanofi buys UK's Kymab and inflammatory disease hopeful for ...

IL-6 drugs do work in COVID-19, says UK, as it plans NHS use

The top 5 pharma M&A deals of 2020

EUSA Pharma hopes IL-6 drug will succeed in COVID-19 where r...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Sanofi

Editor's Picks